CASP8 and acute myeloid leukemia: A therapeutic breakthrough in AML demonstrated that Birinapant, a synthetic small molecule inhibitor of IAP family proteins, is particularly effective when combined with the clinical caspase 8 inhibitor Emricasan/IDN-6556, promoting necroptosis.